Contact us

Ready to innovate your clinical operations with AI? We're here to help.

Whether you have a question about our services, want to discuss a potential project, or simply wish to learn more about how Biorce can help your team, we’d love to hear from you.

Trusted by leading pharma, CRO and biotech companies

SOC 2 Type II Certified and ISO 27001 Compliant

Zero-pressure demo (no follow-up unless requested)

30-minute commitment

Headquarters

Biorce currently has three main headquarters in the United States and Europe and
employees all over the globe.

Biorce currently has three main headquarters in the United States and Europe and employees all over the globe.

Barcelona

Edifici Dau

Av. Diagonal, 615, 2nd & 4th, Les Corts, 08028 Barcelona, Spain.

Open in Maps

New York

WeWork

205 W 37th St 14th floor. New York, NY 10018, United States.

Open in Maps

Austin

823 Congress Ave

823 Congress Ave 12th floor. Austin, TX 78701 United States.

Open in Maps

Locations: Barcelona, New York, Austin, Boston, Lisbon, London.

Biorce

Media hub

Contact

Get the inside track on clinical trial innovation Insights that pharma leaders actually read. No fluff.

Clinical Trials For All participating partner

Partners with

Biorce

Media hub

Contact

Get the inside track on clinical trial innovation Insights that pharma leaders actually read. No fluff.

Partners with

Biorce

Media hub

Contact

Get the inside track on clinical trial innovation Insights that pharma leaders actually read. No fluff.

Partners with

Contact us

Ready to innovate your clinical operations with AI? We're here to help.

Headquarters

Headquarters

Biorce currently has three main headquarters in the United States and Europe andemployees all over the globe.

Biorce currently has three main headquarters in the United States and Europe and employees all over the globe.

Barcelona

Edifici Dau

New York

WeWork

Austin

823 Congress Ave

Biorce currently has three main headquarters in the United States and Europe and
employees all over the globe.